Similar articles

• Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa.

  Lapointe JR, Bourget C, Mainville S, Lafleur L, Lagacé J, Montplaisir S. Lapointe JR, et al. J Chemother. 1989 Jul;1(4 Suppl):184-6. J Chemother. 1989. PMID: 16312360 No abstract available.
• Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.

  Hassett DJ, Sutton MD, Schurr MJ, Herr AB, Caldwell CC, Matu JO. Hassett DJ, et al. Trends Microbiol. 2009 Mar;17(3):130-8. doi: 10.1016/j.tim.2008.12.003. Epub 2009 Feb 21. Trends Microbiol. 2009. PMID: 19231190 Review.
• Pseudomonas aeruginosa infection and cystic fibrosis.

  Kato K, Takayama T. Kato K, et al. Lancet. 2002 Jan 19;359(9302):262. doi: 10.1016/S0140-6736(02)07425-1. Lancet. 2002. PMID: 11812595 No abstract available.
• Epidemiological investigation and glycotyping of clinical Pseudomonas aeruginosa isolates from patients with cystic fibrosis by mass spectrometry: association with multiple drug resistance.

  Altman E, Wang Z, Aaron SD, Liu X, Vandemheen KL, Ferris W, Giesbrecht T, Li J. Altman E, et al. J Microbiol Methods. 2009 Feb;76(2):204-8. doi: 10.1016/j.mimet.2008.10.008. Epub 2008 Oct 28. J Microbiol Methods. 2009. PMID: 19000720
• Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for'.

  Saiman L. Saiman L. Paediatr Respir Rev. 2007 Sep;8(3):249-55. doi: 10.1016/j.prrv.2007.04.006. Epub 2007 Jun 5. Paediatr Respir Rev. 2007. PMID: 17868923 Review.